Table 2 Subject characteristics by treatment group

n

17

17

21

–

Age: Mean (SD)

71 (13)

63 (14)

46 (16)

< 0.001^a

Gender

14 Female

3 Male

10 Female

7 Male

6 Female

15 Male

0.003^a

Ethnicity

5 Black

1 Asian

11 White

6 Black

11 White

5 Black

16 White

NS^a

Iodine concentration mg/ml

Humerus (SD)

3.97 (0.70)

3.97 (0.97)

4.78 (1.22)

0.022^a

Glenoid (SD)

4.51 (1.23)

4.72 (1.24)

5.17 (1.61)

NS^a

Humerus/glenoid (SD)

0.94 (0.27)

0.88 (0.25)

0.96 (0.22)

NS^a

Follow up

12 Months

8

12

NS^b

12 Months with AVN

0

2

NS^b

24 Months

4

10

NS^b

24 Months with AVN

0

3

NS^b

Fracture healing

Healed < 12 months

9

10

NS^b

Healed ≤ 24 months

9

13

NS^b